Sector revisions Genmab A/S Nasdaq

Stocks

Market Closed - Nasdaq Other stock markets 04:00:00 2026-08-07 pm EDT			5-day change	1st Jan Change
31.25 ^USD	+4.76%		+8.24%	+1.46%

Aug. 07	Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data	RE
Aug. 07	Genmab: Q2 beat reinforces the investment story; diversification efforts remain on course

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	WUXI APPTEC CO., LTD.							18
	ARGENX SE							15
	BIONTECH SE							20
	INSMED INCORPORATED							22
	WUXI BIOLOGICS (CAYMAN) INC.							23
	GENMAB A/S							15
	PHARMAESSENTIA CORPORATION							7
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							17
	EXELIXIS, INC.							16
	ARROWHEAD PHARMACEUTICALS, INC.							11
	MADRIGAL PHARMACEUTICALS, INC.							16
	AKESO, INC.							20
	SUMMIT THERAPEUTICS INC.							13
	CYTOKINETICS, INCORPORATED							20
	CRINETICS PHARMACEUTICALS, INC.							10
	REMEGEN CO., LTD.							15
	VAXCYTE, INC.							9
	IMMUNITYBIO, INC.							4
	Average							15
	Weighted average by Cap.							16